SGMT

9.0805.61%
LP

Lucas Pelkmans

Co-Founder

Dr. Lucas Pelkmans, PhD is a Co-Founder of Sagimet Biosciences (formerly known as 3-V Biosciences, Inc.). Dr. Pelkmans was SNF-Professor of Institute of Molecular Systems Biology, ETH Zürich. Dr. Pelkmans discovered an alternative endocytic route that is ligand-activated, involving caveolae along with a new type of endocytic organelle that he named caveosomes. He served as Scientific Advisor at Dewpoint Therapeutics, Inc. since 2021 until 2022. Dr. Pelkmans is recognized for pioneering the Systems Biology approach to identify host genes required for viral infection. He was awarded an Independent Research Professorship from the Swiss National Science Foundation (SNF) (February 2005) and the European Young Investigator (EURYI) (August 2005), having earlier been awarded the ETH medal for his PhD thesis. He spent two years as an EMBO long-term Fellow and Marie Curie Fellow at the Max Planck Institute for Molecular Cell Biology and Genetics in Dresden, Germany. Dr. Pelkmans studied the infectious entry of Simian Virus 40. He holds MS in medical Biology from Utrecht University in 1999 and PhD in Biochemistry from ETH Zürich in 2002. He holds BS in medical Biology from Utrecht University.

Positions